Ledger.Open graph →
SEC Form D · filed October 21, 2024

NLS Pharmaceutics Ltd

Offering
$7.2M
Sold
$7.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ZURICH, V8
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Thilo J. Schroeder · Zurich, V8Exec · DirectorAlexander Zwyer · Zurich, V8Exec · DirectorGian-Marco L. Rinaldi · Zurich, V8DirectorFlorence A. Aknin · Zurich, V8DirectorElena Thyen-Pighin · Zurich, V8ExecAudrey L. Greenberg · Zurich, V8DirectorRonald Hafner · Zurich, V8DirectorClaudio L. Bassetti · Zurich, V8Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗